STATE STREET CORP - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 40 filers reported holding LUMOS PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2023$37,0820.0%11,2370.0%0.00%
Q2 2023$37,082
-2.7%
11,2370.0%0.00%
Q1 2023$38,093
-53.0%
11,237
-50.0%
0.00%
Q4 2022$81,132
-18.0%
22,474
+100.0%
0.00%
Q3 2022$99,000
+13.8%
11,2370.0%0.00%
Q2 2022$87,000
-17.9%
11,2370.0%0.00%
Q1 2022$106,000
+35.9%
11,2370.0%0.00%
Q4 2021$78,000
-27.1%
11,2370.0%0.00%
Q3 2021$107,000
-4.5%
11,2370.0%0.00%
Q2 2021$112,00011,2370.00%
Other shareholders
LUMOS PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Lion Point Capital, LP 407,192$5,627,0001.23%
Opaleye Management Inc. 240,892$3,329,0000.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 936,291$12,940,0000.32%
NEA Management Company, LLC 526,663$7,278,0000.31%
Investors Financial Group, LLC 21,766$301,0000.22%
Wealth Advisors of Iowa, LLC 11,760$163,0000.11%
Blackstone Inc. 468,145$6,470,0000.02%
Jefferies Group LLC 120,651$1,667,0000.02%
Texas Yale Capital Corp. 16,000$221,0000.02%
Prospera Financial Services Inc 1,088$15,0000.01%
View complete list of LUMOS PHARMA INC shareholders